These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29156221)

  • 1. Novel recruitment models will drive Alzheimer's trial success.
    Vidoni ED; Bothwell RJ; Burns JM; Dwyer JR
    Alzheimers Dement; 2018 Jan; 14(1):117-119. PubMed ID: 29156221
    [No Abstract]   [Full Text] [Related]  

  • 2. The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutions.
    Fargo KN; Carrillo MC; Weiner MW; Potter WZ; Khachaturian Z
    Alzheimers Dement; 2016 Nov; 12(11):1113-1115. PubMed ID: 27836052
    [No Abstract]   [Full Text] [Related]  

  • 3. Obstacles and opportunities in Alzheimer's clinical trial recruitment.
    Watson JL; Ryan L; Silverberg N; Cahan V; Bernard MA
    Health Aff (Millwood); 2014 Apr; 33(4):574-9. PubMed ID: 24711317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constructing a Local Potential Participant Registry to Improve Alzheimer's Disease Clinical Research Recruitment.
    Grill JD; Hoang D; Gillen DL; Cox CG; Gombosev A; Klein K; O'Leary S; Witbracht M; Pierce A
    J Alzheimers Dis; 2018; 63(3):1055-1063. PubMed ID: 29710723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural imaging markers for therapeutic trials in Alzheimer's disease.
    Fox NC; Kennedy J
    J Nutr Health Aging; 2009 Apr; 13(4):350-2. PubMed ID: 19300877
    [No Abstract]   [Full Text] [Related]  

  • 6. Recruitment and enrollment of caregivers for a lifestyle physical activity clinical trial.
    Etkin CD; Farran CJ; Barnes LL; Shah RC
    Res Nurs Health; 2012 Feb; 35(1):70-81. PubMed ID: 22083931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recruitment of At-Risk Participants for Clinical Trials: A Major Paradigm Shift for Alzheimer's Disease Prevention.
    Alber J; Lee AKW; Menard W; Monast D; Salloway SP
    J Prev Alzheimers Dis; 2017; 4(4):213-214. PubMed ID: 29181484
    [No Abstract]   [Full Text] [Related]  

  • 8. Recruitment, retention and other methodological issues related to clinical trials for Alzheimer's disease.
    Vellas B
    J Nutr Health Aging; 2012 Apr; 16(4):330. PubMed ID: 22499451
    [No Abstract]   [Full Text] [Related]  

  • 9. The Effectiveness of Small-group Community-based Information Sessions on Clinical Trial Recruitment for Secondary Prevention of Alzheimer's Disease.
    Tarrant SD; Bardach SH; Bates K; Nichols H; Towner J; Tamatha C; Caban-Holt A; Van-Eldik LJ; Murphy RR; Sperling R; Jicha GA
    Alzheimer Dis Assoc Disord; 2017; 31(2):141-145. PubMed ID: 27213625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical Considerations for Deep Brain Stimulation Trials in Patients with Early-Onset Alzheimer's Disease.
    Viaña JNM; Bittlinger M; Gilbert F
    J Alzheimers Dis; 2017; 58(2):289-301. PubMed ID: 28436389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical Issues in the Development of Readiness Cohorts in Alzheimer's Disease Research.
    Milne R; Bunnik E; Tromp K; Bemelmans S; Badger S; Gove D; Maman M; Schermer M; Truyen L; Brayne C; Richard E
    J Prev Alzheimers Dis; 2017; 4(2):125-131. PubMed ID: 29186282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing Health Disparities Among Minority Populations: Why Clinical Trial Recruitment Is Not Enough.
    Wilkins CH; Schindler SE; Morris JC
    JAMA Neurol; 2020 Sep; 77(9):1063-1064. PubMed ID: 32539100
    [No Abstract]   [Full Text] [Related]  

  • 13. Genentech's Alzheimer's antibody trial to study disease prevention.
    Garber K
    Nat Biotechnol; 2012 Aug; 30(8):731-2. PubMed ID: 22871696
    [No Abstract]   [Full Text] [Related]  

  • 14. Mixed dementia in clinical trials of Alzheimer's disease.
    Massoud F
    Can J Neurol Sci; 2012 Sep; 39(5):566-7. PubMed ID: 22931693
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel approaches to Alzheimer's disease therapeutics.
    Chohan MO
    J Alzheimers Dis; 2008 Oct; 15(2):155-6. PubMed ID: 18953104
    [No Abstract]   [Full Text] [Related]  

  • 16. Alzheimer's research. How to talk about Alzheimer's risk.
    Miller G
    Science; 2012 Aug; 337(6096):792. PubMed ID: 22903992
    [No Abstract]   [Full Text] [Related]  

  • 17. Searching for Alzheimer's disease therapies.
    Stower H
    Nat Med; 2018 Jul; 24(7):894-897. PubMed ID: 29988132
    [No Abstract]   [Full Text] [Related]  

  • 18. Current and future management of Alzheimer's disease.
    Gauthier S; Poirier J
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S48-50. PubMed ID: 18632000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What We Learn from the CTAD (Clinical Trials Alzheimer's Disease) 2018.
    Vellas B; Aisen P; Weiner M; Touchon J
    J Prev Alzheimers Dis; 2018; 5(4):214-215. PubMed ID: 30298178
    [No Abstract]   [Full Text] [Related]  

  • 20. Call for Elan to publish Alzheimer's trial details.
    Bishop GM; Robinson SR; Smith MA; Perry G; Atwood CS
    Nature; 2002 Apr; 416(6882):677. PubMed ID: 11961526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.